These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 15243309
1. Cilostazol and dipyridamole synergistically inhibit human platelet aggregation. Liu Y, Cone J, Le SN, Fong M, Tao L, Shoaf SE, Bricmont P, Czerwiec FS, Kambayashi J, Yoshitake M, Sun B. J Cardiovasc Pharmacol; 2004 Aug; 44(2):266-73. PubMed ID: 15243309 [Abstract] [Full Text] [Related]
7. Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo. Minami N, Suzuki Y, Yamamoto M, Kihira H, Imai E, Wada H, Kimura Y, Ikeda Y, Shiku H, Nishikawa M. Life Sci; 1997 Aug; 61(25):PL 383-9. PubMed ID: 9416770 [Abstract] [Full Text] [Related]
8. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233. Dawicki DD, Agarwal KC, Parks RE. Thromb Res; 1986 Jul 15; 43(2):161-75. PubMed ID: 3016942 [Abstract] [Full Text] [Related]
10. Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Liu Y, Shakur Y, Yoshitake M, Kambayashi Ji J. Cardiovasc Drug Rev; 2001 Jul 15; 19(4):369-86. PubMed ID: 11830753 [Abstract] [Full Text] [Related]
20. [Inhibition of induced thrombocyte aggregation in the presence of endothelial cells by dipyridamole]. Kirchmaier CM, Altorjay J, Bellinger O, Breddin HK. Vasa Suppl; 1991 Aug 01; 32():318-21. PubMed ID: 1771524 [Abstract] [Full Text] [Related] Page: [Next] [New Search]